143 related articles for article (PubMed ID: 16210624)
1. Splenic marginal zone dendritic cells mediate the cholera toxin adjuvant effect: dependence on the ADP-ribosyltransferase activity of the holotoxin.
Grdic D; Ekman L; Schön K; Lindgren K; Mattsson J; Magnusson KE; Ricciardi-Castagnoli P; Lycke N
J Immunol; 2005 Oct; 175(8):5192-202. PubMed ID: 16210624
[TBL] [Abstract][Full Text] [Related]
2. ADP-ribosylating bacterial enzymes for the targeted control of mucosal tolerance and immunity.
Lycke N
Ann N Y Acad Sci; 2004 Dec; 1029():193-208. PubMed ID: 15681758
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cell-mediated induction of mucosal cytotoxic responses following intravaginal immunization with the nontoxic B subunit of cholera toxin.
Luci C; Hervouet C; Rousseau D; Holmgren J; Czerkinsky C; Anjuère F
J Immunol; 2006 Mar; 176(5):2749-57. PubMed ID: 16493030
[TBL] [Abstract][Full Text] [Related]
4. Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 development.
Eriksson K; Fredriksson M; Nordström I; Holmgren J
Infect Immun; 2003 Apr; 71(4):1740-7. PubMed ID: 12654787
[TBL] [Abstract][Full Text] [Related]
5. From toxin to adjuvant: basic mechanisms for the control of mucosal IgA immunity and tolerance.
Lycke N
Immunol Lett; 2005 Mar; 97(2):193-8. PubMed ID: 15752558
[TBL] [Abstract][Full Text] [Related]
6. The Nontoxic Cholera B Subunit Is a Potent Adjuvant for Intradermal DC-Targeted Vaccination.
Antonio-Herrera L; Badillo-Godinez O; Medina-Contreras O; Tepale-Segura A; García-Lozano A; Gutierrez-Xicotencatl L; Soldevila G; Esquivel-Guadarrama FR; Idoyaga J; Bonifaz LC
Front Immunol; 2018; 9():2212. PubMed ID: 30319653
[TBL] [Abstract][Full Text] [Related]
7. Modulating dendritic cells to optimize mucosal immunization protocols.
Williamson E; Westrich GM; Viney JL
J Immunol; 1999 Oct; 163(7):3668-75. PubMed ID: 10490961
[TBL] [Abstract][Full Text] [Related]
8. Vaccination with dendritic cells pulsed in vitro with tumor antigen conjugated to cholera toxin efficiently induces specific tumoricidal CD8+ cytotoxic lymphocytes dependent on cyclic AMP activation of dendritic cells.
Sun JB; Eriksson K; Li BL; Lindblad M; Azem J; Holmgren J
Clin Immunol; 2004 Jul; 112(1):35-44. PubMed ID: 15207780
[TBL] [Abstract][Full Text] [Related]
9. Influence of mucosal adjuvants on antigen passage and CD4+ T cell activation during the primary response to airborne allergen.
Wikstrom ME; Batanero E; Smith M; Thomas JA; von Garnier C; Holt PG; Stumbles PA
J Immunol; 2006 Jul; 177(2):913-24. PubMed ID: 16818746
[TBL] [Abstract][Full Text] [Related]
10. Cholera toxin activates dendritic cells through dependence on GM1-ganglioside which is mediated by NF-kappaB translocation.
Kawamura YI; Kawashima R; Shirai Y; Kato R; Hamabata T; Yamamoto M; Furukawa K; Fujihashi K; McGhee JR; Hayashi H; Dohi T
Eur J Immunol; 2003 Nov; 33(11):3205-12. PubMed ID: 14579289
[TBL] [Abstract][Full Text] [Related]
11. Cholera toxin promotes the induction of regulatory T cells specific for bystander antigens by modulating dendritic cell activation.
Lavelle EC; McNeela E; Armstrong ME; Leavy O; Higgins SC; Mills KH
J Immunol; 2003 Sep; 171(5):2384-92. PubMed ID: 12928385
[TBL] [Abstract][Full Text] [Related]
12. B lymphocytes promote expansion of regulatory T cells in oral tolerance: powerful induction by antigen coupled to cholera toxin B subunit.
Sun JB; Flach CF; Czerkinsky C; Holmgren J
J Immunol; 2008 Dec; 181(12):8278-87. PubMed ID: 19050244
[TBL] [Abstract][Full Text] [Related]
13. Analysis of adjuvant function by direct visualization of antigen presentation in vivo: endotoxin promotes accumulation of antigen-bearing dendritic cells in the T cell areas of lymphoid tissue.
Reis e Sousa C; Germain RN
J Immunol; 1999 Jun; 162(11):6552-61. PubMed ID: 10352271
[TBL] [Abstract][Full Text] [Related]
14. Transcutaneous immunization with cholera toxin B subunit adjuvant suppresses IgE antibody responses via selective induction of Th1 immune responses.
Anjuère F; George-Chandy A; Audant F; Rousseau D; Holmgren J; Czerkinsky C
J Immunol; 2003 Feb; 170(3):1586-92. PubMed ID: 12538724
[TBL] [Abstract][Full Text] [Related]
15. Direct interaction between cholera toxin and dendritic cells is required for oral adjuvant activity.
Gustafsson T; Hua YJ; Dahlgren MW; Livingston M; Johansson-Lindbom B; Yrlid U
Eur J Immunol; 2013 Jul; 43(7):1779-88. PubMed ID: 23649516
[TBL] [Abstract][Full Text] [Related]
16. Sublingual tolerance induction with antigen conjugated to cholera toxin B subunit induces Foxp3+CD25+CD4+ regulatory T cells and suppresses delayed-type hypersensitivity reactions.
Sun JB; Cuburu N; Blomquist M; Li BL; Czerkinsky C; Holmgren J
Scand J Immunol; 2006 Sep; 64(3):251-9. PubMed ID: 16918694
[TBL] [Abstract][Full Text] [Related]
17. HMGB1 released from intestinal epithelia damaged by cholera toxin adjuvant contributes to activation of mucosal dendritic cells and induction of intestinal cytotoxic T lymphocytes and IgA.
Wakabayashi A; Shimizu M; Shinya E; Takahashi H
Cell Death Dis; 2018 May; 9(6):631. PubMed ID: 29795370
[TBL] [Abstract][Full Text] [Related]
18. CCR7-CCL19/CCL21-regulated dendritic cells are responsible for effectiveness of sublingual vaccination.
Song JH; Kim JI; Kwon HJ; Shim DH; Parajuli N; Cuburu N; Czerkinsky C; Kweon MN
J Immunol; 2009 Jun; 182(11):6851-60. PubMed ID: 19454681
[TBL] [Abstract][Full Text] [Related]
19. Pertussis toxin enhances Th1 responses by stimulation of dendritic cells.
Hou W; Wu Y; Sun S; Shi M; Sun Y; Yang C; Pei G; Gu Y; Zhong C; Sun B
J Immunol; 2003 Feb; 170(4):1728-36. PubMed ID: 12574336
[TBL] [Abstract][Full Text] [Related]
20. Murine Flt3 ligand expands distinct dendritic cells with both tolerogenic and immunogenic properties.
Miller G; Pillarisetty VG; Shah AB; Lahrs S; DeMatteo RP
J Immunol; 2003 Apr; 170(7):3554-64. PubMed ID: 12646617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]